Combination of Recombinant Human Erythropoietin with Iron Preparation (III) for Intravenous Administration in Oncohematology (Clinical Case)

The clinical observation of treatment of a 59-year-old patient who has been diagnosed with multiple myeloma has been presented. Anemia and iron deficiency are frequent undesirable complications in patients with multiple myeloma and haematological malignancies, including those induced by chemotherapy. The article describes the modern principles of managing patients with anemia of malignant growth, taking into account the latest recommendations of the European Society of Clinical Oncologists in 2018. Over the past years, our understanding of the importance of anemia in cancer patients has dramatically increased.

Keywords: anemia, multiple myeloma, erythropoietin, Emavail, treatment.